Company Filing History:
Years Active: 2025
Title: Claudio Sturino: Innovator in GPR84 Antagonists
Introduction
Claudio Sturino is a notable inventor based in L'ile-Bizard, Canada. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target GPR84-mediated disorders. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Sturino holds a patent for "GPR84 antagonists and uses thereof." This invention provides compounds and compositions that inhibit GPR84, offering potential treatments for various disorders associated with this receptor. The patent highlights the importance of GPR84 in therapeutic applications and underscores Sturino's role in pioneering research in this area.
Career Highlights
Claudio Sturino is associated with Liminal Biosciences Limited, where he collaborates with a team of skilled professionals. His work at the company focuses on developing innovative solutions for health-related challenges. Sturino's career is marked by his commitment to research and his ability to translate scientific discoveries into practical applications.
Collaborations
Sturino has worked alongside talented colleagues such as Shaun Abbott and Mylène De Léséleuc. Their collaborative efforts contribute to the advancement of research and the development of new therapeutic strategies.
Conclusion
Claudio Sturino is a distinguished inventor whose work on GPR84 antagonists has the potential to impact the treatment of various disorders. His contributions to the field of pharmacology reflect his dedication to innovation and collaboration in scientific research.